FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry and concerns the use of alpha-hydroxycarbonyl compounds as reducing substances able to form cyclic dimers. Also, there are presented related methods for reducing the reduced compounds, especially activated by compound reduction. The examples of the used alpha-hydroxycarbonyl compounds are dihydroacetone, glyceraldehyde, erythrose, xylulose, erythrulose or 3-hydroxy-2-butanone.
EFFECT: reduction takes place in mild conditions and provides selective production of one of isomers of the reduced compound.
54 cl, 9 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF DANTROLENE AND DANTROLENE PRODRUGS FOR TREATMENT OF RADIATION EXPOSURE | 2019 |
|
RU2812220C2 |
| COMPOUNDS MODULATING INTRACELLULAR CALCIUM | 2008 |
|
RU2465272C2 |
| DANTROLENE PRODRUGS AND METHODS OF THEIR USE | 2018 |
|
RU2815017C2 |
| ALPHA-SUBSTITUTED OMEGA-3 LIPIDS, ACTIVATORS OR MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) | 2007 |
|
RU2507193C2 |
| BENZAMIDE DERIVATIVES HAVING ANTICANCER ACTIVITY, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2011 |
|
RU2565079C2 |
| CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
| PRODRUGS CONTAINING EXENDIN CONJUGATE-LINKER | 2011 |
|
RU2593774C2 |
| 1-(2-FLUOROBIPHENYL-4-YL)-ALKYLCARBOXYLIC ACID DERIVATIVES FOR TREATING TRANSTHYRETIN AMYLOIDOSIS | 2011 |
|
RU2565066C2 |
| NEW NITROPHENYLPYRITE AND NITROPHENYLAZIRIDINE ALCOHOLS AND CORRESPONDING PHOSPHATES THEREOF AND USE THEREOF AS TARGETED CYTOTOXIC AGENTS | 2004 |
|
RU2372324C2 |
| QUINONE COMPOUNDS AND USING THEM FOR TREATING CANCER | 2013 |
|
RU2688675C2 |
